{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T11:04:46Z","timestamp":1761822286550,"version":"build-2065373602"},"reference-count":32,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.es","revespcardiol.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Espa\u00f1ola de Cardiolog\u00eda (English Edition)"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.rec.2023.06.020","type":"journal-article","created":{"date-parts":[[2023,10,23]],"date-time":"2023-10-23T15:29:39Z","timestamp":1698074979000},"page":"150-157","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Single antiplatelet therapy after left atrial appendage closure in patients with AF: safety and effectiveness"],"prefix":"10.1016","volume":"77","author":[{"given":"Marc","family":"Llagostera-Mart\u00edn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel","family":"Cainzos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neus","family":"Salvatella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H\u00e9ctor","family":"Cubero-Gallego","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aleksandra","family":"Mas-Stachurska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"S\u00e1nchez-Carpintero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helena","family":"Tiz\u00f3n-Marcos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alicia","family":"Calvo-Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis","family":"Molina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatriz","family":"Vaquerizo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rec.2023.06.020_bib0165","first-page":"373","article-title":"The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC)","volume":"42","author":"Hindriks","year":"2020","journal-title":"Eur Heart J."},{"key":"10.1016\/j.rec.2023.06.020_bib0170","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.4244\/EIJV15I13A207","article-title":"Left atrial appendage occlusion for stroke prevention - state of the art as provided in an updated EHRA\/EAPCI consensus statement and future perspectives","volume":"15","author":"Skurk","year":"2020","journal-title":"EuroIntervention."},{"key":"10.1016\/j.rec.2023.06.020_bib0175","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1161\/CIRCULATIONAHA.112.114389","article-title":"Percutaneous Left Atrial Appendage Closure for Stroke Prophylaxis in Patients with Atrial Fibrillation: 2.3-Year Follow-up of the PROTECT AF (Watchman Left Atrial Appendage System for Embolic Protection in Patients with Atrial Fibrillation) Trial","volume":"127","author":"Reddy","year":"2013","journal-title":"Circulation."},{"key":"10.1016\/j.rec.2023.06.020_bib0180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2014.04.029","article-title":"Prospective Randomized Evaluation of the Watchman Left Atrial Appendage Closure Device in Patients with Atrial Fibrillation Versus Long-Term Warfarin Therapy","volume":"64","author":"Holmes","year":"2014","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.rec.2023.06.020_bib0185","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/S0140-6736(09)61343-X","article-title":"Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial","volume":"374","author":"Holmes","year":"2009","journal-title":"Lancet."},{"key":"10.1016\/j.rec.2023.06.020_bib0190","first-page":"E111","article-title":"Device-associated thrombus formation after left atrial appendage occlusion: A systematic review of events reported with the Watchman, the Amplatzer Cardiac Plug and the Amulet: Device-Related Thrombosis After LAAO","volume":"90","author":"Lempereur","year":"2017","journal-title":"Catheter Cardiovasc Interv."},{"key":"10.1016\/j.rec.2023.06.020_bib0195","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1016\/j.jacc.2018.01.076","article-title":"Device-related Thrombosis After Percutaneous Left Atrial Appendage Occlusion for Atrial Fibrillation","volume":"71","author":"Fauchier","year":"2018","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.rec.2023.06.020_bib0200","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1007\/s00392-015-0828-1","article-title":"Early results of first versus second generation Amplatzer occluders for left atrial appendage closure in patients with atrial fibrillation","volume":"104","author":"Gloekler","year":"2015","journal-title":"Clin Res Cardiol."},{"key":"10.1016\/j.rec.2023.06.020_bib0205","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1586\/14779072.2015.988612","article-title":"Antithrombotic therapy after left atrial appendage closure","volume":"13","author":"Schmidt","year":"2015","journal-title":"Expert Rev Cardiovasc Ther."},{"key":"10.1016\/j.rec.2023.06.020_bib0210","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1016\/j.jcin.2017.06.072","article-title":"Percutaneous Left Atrial Appendage Closure with the LAmbre Device for Stroke Prevention in Atrial Fibrillation","volume":"10","author":"Huang","year":"2017","journal-title":"JACC Cardiovasc Interv."},{"key":"10.1016\/j.rec.2023.06.020_bib0215","doi-asserted-by":"crossref","first-page":"678","DOI":"10.21037\/cdt.2018.06.08","article-title":"Antiplatelet therapy in valvular and structural heart disease interventions","volume":"8","author":"Nusca","year":"2018","journal-title":"Cardiovasc Diagn Ther."},{"key":"10.1016\/j.rec.2023.06.020_bib0220","doi-asserted-by":"crossref","first-page":"e006841","DOI":"10.1161\/CIRCEP.118.006841","article-title":"Evaluating Real-world Clinical Outcomes in Atrial Fibrillation Patients Receiving the WATCHMAN Left Atrial Appendage Closure Technology: Final 2-Year Outcome Data of the EWOLUTION Trial Focusing on History of Stroke and Hemorrhage","volume":"12","author":"Boersma","year":"2019","journal-title":"Circ Arrhythm Electrophysiol."},{"key":"10.1016\/j.rec.2023.06.020_bib0225","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1016\/j.jacc.2017.10.021","article-title":"5-Year Outcomes After Left Atrial Appendage Closure","volume":"70","author":"Reddy","year":"2017","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.rec.2023.06.020_bib0230","doi-asserted-by":"crossref","first-page":"e007257","DOI":"10.1161\/CIRCEP.119.007257","article-title":"EWOLUTION of Watchman Left Atrial Appendage Closure to Patients with Contraindication to Oral Anticoagulation","volume":"12","author":"Turagam","year":"2019","journal-title":"Circ Arrhythm Electrophysiol."},{"key":"10.1016\/j.rec.2023.06.020_bib0235","first-page":"1036","article-title":"Initial and long-term antithrombotic therapy after left atrial appendage closure with the WATCHMAN","volume":"22","author":"Ledwoch","year":"2020","journal-title":"EP Eur."},{"key":"10.1016\/j.rec.2023.06.020_bib0240","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1378\/chest.09-1584","article-title":"Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach","volume":"137","author":"Lip","year":"2010","journal-title":"Chest."},{"key":"10.1016\/j.rec.2023.06.020_bib0245","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1378\/chest.10-0134","article-title":"A Novel User-friendly Score (HAS-BLED) to Assess 1-Year Risk of Major Bleeding in Patients with Atrial Fibrillation","volume":"138","author":"Pisters","year":"2010","journal-title":"Chest."},{"key":"10.1016\/j.rec.2023.06.020_bib0250","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1161\/CIRCULATIONAHA.110.009449","article-title":"Standardized Bleeding Definitions for Cardiovascular Clinical Trials: A Consensus Report From the Bleeding Academic Research Consortium","volume":"123","author":"Mehran","year":"2011","journal-title":"Circulation."},{"key":"10.1016\/j.rec.2023.06.020_bib0255","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1093\/eurheartj\/ehr488","article-title":"Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study","volume":"33","author":"Friberg","year":"2012","journal-title":"Eur Heart J."},{"key":"10.1016\/j.rec.2023.06.020_bib0260","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1161\/CIRCULATIONAHA.118.035764","article-title":"Left Atrial Appendage Closure: Two Steps Forward, One Step Back","volume":"138","author":"Ellis","year":"2018","journal-title":"Circulation."},{"key":"10.1016\/j.rec.2023.06.020_bib0265","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.jcin.2018.11.001","article-title":"Antithrombotic Therapy and Device-Related Thrombosis Following Endovascular Left Atrial Appendage Closure","volume":"12","author":"Saw","year":"2019","journal-title":"JACC Cardiovasc Interv."},{"key":"10.1016\/j.rec.2023.06.020_bib0270","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.jcin.2016.11.029","article-title":"Incidence and Clinical Impact of Device-Associated Thrombus and Peri-Device Leak Following Left Atrial Appendage Closure with the Amplatzer Cardiac Plug","volume":"10","author":"Saw","year":"2017","journal-title":"JACC Cardiovasc Interv."},{"key":"10.1016\/j.rec.2023.06.020_bib0275","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1161\/CIRCULATIONAHA.118.035090","article-title":"Device-related Thrombus After Left Atrial Appendage Closure: Incidence, Predictors, and Outcomes","volume":"138","author":"Dukkipati","year":"2018","journal-title":"Circulation."},{"key":"10.1016\/j.rec.2023.06.020_bib0280","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.jacc.2021.04.098","article-title":"Predictors of Device-related Thrombus Following Percutaneous Left Atrial Appendage Occlusion","volume":"78","author":"Simard","year":"2021","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.rec.2023.06.020_bib0285","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.ijcard.2018.02.120","article-title":"Left atrial appendage occlusion with LAmbre in atrial fibrillation: Initial European experience","volume":"265","author":"Park","year":"2018","journal-title":"Int J Cardiol."},{"key":"10.1016\/j.rec.2023.06.020_bib0290","first-page":"251","article-title":"Percutaneous left atrial appendage closure using the LAmbre device. First clinical results in Poland","volume":"15","author":"Burysz","year":"2019","journal-title":"Adv Interv Cardiol."},{"key":"10.1016\/j.rec.2023.06.020_bib0295","doi-asserted-by":"crossref","first-page":"491","DOI":"10.2459\/JCM.0000000000000663","article-title":"Initial experience of percutaneous left atrial appendage closure using the LAmbre device for thromboembolic prevention:","volume":"19","author":"Reinsch","year":"2018","journal-title":"J Cardiovasc Med."},{"key":"10.1016\/j.rec.2023.06.020_bib0300","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.carrev.2013.04.003","article-title":"A new left atrial appendage occluder (Lifetech LAmbreTM Device) for stroke prevention in atrial fibrillation","volume":"14","author":"Lam","year":"2013","journal-title":"Cardiovasc Revasc Med."},{"key":"10.1016\/j.rec.2023.06.020_bib0305","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.4244\/EIJY15M01_06","article-title":"Left atrial appendage occlusion for stroke prevention in atrial fibrillation: multicentre experience with the AMPLATZER Cardiac Plug","volume":"11","author":"Tzikas","year":"2016","journal-title":"EuroIntervention."},{"key":"10.1016\/j.rec.2023.06.020_bib0310","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.4244\/EIJ-D-16-00726","article-title":"Transcatheter left atrial appendage occlusion in patients with atrial fibrillation and a high bleeding risk using aspirin alone for post-implant antithrombotic therapy","volume":"12","author":"Korsholm","year":"2017","journal-title":"EuroIntervention."},{"key":"10.1016\/j.rec.2023.06.020_bib0315","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.4244\/EIJ-D-17-00901","article-title":"Short-term dual antiplatelet therapy after interventional left atrial appendage closure with different devices","volume":"13","author":"Weise","year":"2018","journal-title":"EuroIntervention."},{"key":"10.1016\/j.rec.2023.06.020_bib0320","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1093\/ndt\/gft209","article-title":"Haemostasis in chronic kidney disease","volume":"29","author":"Lutz","year":"2014","journal-title":"Nephrol Dial Transplant."}],"container-title":["Revista Espa\u00f1ola de Cardiolog\u00eda (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1885585723002761?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1885585723002761?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T11:02:29Z","timestamp":1761822149000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1885585723002761"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S1885585723002761"],"URL":"https:\/\/doi.org\/10.1016\/j.rec.2023.06.020","relation":{},"ISSN":["1885-5857"],"issn-type":[{"type":"print","value":"1885-5857"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Single antiplatelet therapy after left atrial appendage closure in patients with AF: safety and effectiveness","name":"articletitle","label":"Article Title"},{"value":"Revista Espa\u00f1ola de Cardiolog\u00eda (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rec.2023.06.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.recesp.2023.06.005","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Sociedad Espa\u00f1ola de Cardiolog\u00eda. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}